Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Operating Leases: 2021-2024

Historic Operating Leases for Organogenesis Holdings (ORGO) over the last 4 years, with Dec 2024 value amounting to $25.2 million.

  • Organogenesis Holdings' Operating Leases rose 3.17% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 3.17%. This contributed to the annual value of $25.2 million for FY2024, which is 0.58% up from last year.
  • Per Organogenesis Holdings' latest filing, its Operating Leases stood at $25.2 million for FY2024, which was up 0.58% from $25.1 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Operating Leases ranged from a high of $46.9 million in FY2021 and a low of $20.9 million during FY2022.
  • Its 3-year average for Operating Leases is $23.7 million, with a median of $25.1 million in 2023.
  • Its Operating Leases has fluctuated over the past 5 years, first tumbled by 55.33% in 2022, then climbed by 19.60% in 2023.
  • Over the past 4 years, Organogenesis Holdings' Operating Leases (Yearly) stood at $46.9 million in 2021, then slumped by 55.33% to $20.9 million in 2022, then increased by 19.60% to $25.1 million in 2023, then increased by 0.58% to $25.2 million in 2024.